Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
18
pubmed:dateCreated
1988-10-13
pubmed:abstractText
Models of the Fv portion (containing the variable regions of the heavy and light chains) of two monoclonal anti-alpha (1----6)dextran antibodies, W3129 and 19.1.2, were constructed from amino acid sequences and the known three-dimensional structures of the Fv portions of McPC603 and J539. The modeled combining site of W3129 has a protrusion on one side, formed by the long complementarity-determining region 1 of the light chain and the long complementarity-determining region 3 of the heavy chain, and has a cavity accommodating a glucose moiety. The model of the 19.1.2 site is basically flat with a shallow groove that can accommodate several internal glucose units. These results support the earlier conclusions, from ligand binding data, that W3129 has a cavity-type site, involving the terminal nonreducing glucose residue (endbinder), whereas 19.1.2 has a groove-type site.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/2457920-17883, http://linkedlifedata.com/resource/pubmed/commentcorrection/2457920-2414276, http://linkedlifedata.com/resource/pubmed/commentcorrection/2457920-2414277, http://linkedlifedata.com/resource/pubmed/commentcorrection/2457920-2415605, http://linkedlifedata.com/resource/pubmed/commentcorrection/2457920-2436230, http://linkedlifedata.com/resource/pubmed/commentcorrection/2457920-2438345, http://linkedlifedata.com/resource/pubmed/commentcorrection/2457920-268248, http://linkedlifedata.com/resource/pubmed/commentcorrection/2457920-2893825, http://linkedlifedata.com/resource/pubmed/commentcorrection/2457920-3090684, http://linkedlifedata.com/resource/pubmed/commentcorrection/2457920-3097327, http://linkedlifedata.com/resource/pubmed/commentcorrection/2457920-3115981, http://linkedlifedata.com/resource/pubmed/commentcorrection/2457920-3116402, http://linkedlifedata.com/resource/pubmed/commentcorrection/2457920-3309349, http://linkedlifedata.com/resource/pubmed/commentcorrection/2457920-3449853, http://linkedlifedata.com/resource/pubmed/commentcorrection/2457920-3449860, http://linkedlifedata.com/resource/pubmed/commentcorrection/2457920-3796632, http://linkedlifedata.com/resource/pubmed/commentcorrection/2457920-3890687, http://linkedlifedata.com/resource/pubmed/commentcorrection/2457920-4093982, http://linkedlifedata.com/resource/pubmed/commentcorrection/2457920-476721, http://linkedlifedata.com/resource/pubmed/commentcorrection/2457920-49389, http://linkedlifedata.com/resource/pubmed/commentcorrection/2457920-6085753, http://linkedlifedata.com/resource/pubmed/commentcorrection/2457920-6092095, http://linkedlifedata.com/resource/pubmed/commentcorrection/2457920-6399980, http://linkedlifedata.com/resource/pubmed/commentcorrection/2457920-6504141, http://linkedlifedata.com/resource/pubmed/commentcorrection/2457920-6548294, http://linkedlifedata.com/resource/pubmed/commentcorrection/2457920-875032, http://linkedlifedata.com/resource/pubmed/commentcorrection/2457920-89832
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0027-8424
pubmed:author
pubmed:issnType
Print
pubmed:volume
85
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
6885-9
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1988
pubmed:articleTitle
Model-building study of the combining sites of two antibodies to alpha (1----6)dextran.
pubmed:affiliation
Laboratory of Molecular Biology, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD 20892.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, U.S. Gov't, Non-P.H.S.